Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.
暂无分享,去创建一个
Pauline M. Rudd | P. Rudd | J. Bones | A. Năstase | Ciara A. McManus | Jonathan Bones | Jennifer C. Byrne | Niaobh O'Donoghue | Caitriona Scaife | Herve Boissin | Anca Nastase | C. Scaife | J. Byrne | H. Boissin | C. McManus | Niaobh O'Donoghue
[1] J. Lafitte,et al. Tumor Necrosis Factor α Increases the Expression of Glycosyltransferases and Sulfotransferases Responsible for the Biosynthesis of Sialylated and/or Sulfated Lewis x Epitopes in the Human Bronchial Mucosa* , 2002, The Journal of Biological Chemistry.
[2] A. Varki,et al. Diversity in cell surface sialic acid presentations: implications for biology and disease , 2007, Laboratory Investigation.
[3] Ajit Varki,et al. Perspectives on the significance of altered glycosylation of glycoproteins in cancer , 1997, Glycoconjugate Journal.
[4] H. Sohn,et al. Identification of target proteins of N‐acetylglucosaminyl‐transferase V and fucosyltransferase 8 in human gastric tissues by glycomic approach , 2004, Proteomics.
[5] R. Dwek,et al. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. , 2006, Immunology letters.
[6] Michelle L. Reyzer,et al. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. , 2010, Journal of proteome research.
[7] U. Landegren,et al. MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas. , 2010, Glycobiology.
[8] S. Hanash,et al. Towards an integrated proteomic and glycomic approach to finding cancer biomarkers , 2009, Genome Medicine.
[9] Pauline M. Rudd,et al. GlycoBase and autoGU: tools for HPLC-based glycan analysis , 2008, Bioinform..
[10] Sudhir Srivastava,et al. Posttranslational Protein Modifications , 2006, Molecular & Cellular Proteomics.
[11] D. Isenberg,et al. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. , 1992, The Journal of clinical investigation.
[12] L. Xin,et al. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[13] A. Umemoto,et al. Proteomic alteration in gastic adenocarcinomas from Japanese patients , 2006, Molecular Cancer.
[14] Osamu Ishikawa,et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation , 2006, International journal of cancer.
[15] David J. Harvey,et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. , 2008, Analytical biochemistry.
[16] U. Settmacher,et al. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach. , 2005, Journal of proteome research.
[17] P. Schlag,et al. Clinical Relevance of Sialyltransferases ST6GAL-I and ST3GAL-III in Gastric Cancer , 2003, Oncology.
[18] R. Jemmerson,et al. Serum leucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay , 2006, Apoptosis.
[19] S. Leung,et al. Diverse proteomic alterations in gastric adenocarcinoma , 2004, Proteomics.
[20] M. Rapala-Kozik,et al. Kininogen binding to the surfaces of macrophages. , 2008, International immunopharmacology.
[21] Pauline M Rudd,et al. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. , 2008, Glycobiology.
[22] J. Tschopp,et al. Clusterin: the intriguing guises of a widely expressed glycoprotein. , 1992, Trends in biochemical sciences.
[23] Yehia Mechref,et al. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. , 2008, Clinical chemistry.
[24] Kathryn S Lilley,et al. Maximising sensitivity for detecting changes in protein expression: Experimental design using minimal CyDyes , 2005, Proteomics.
[25] S. Nordling,et al. COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer , 2009, Tumor Biology.
[26] Z. Ye,et al. SPARC Is Associated with Gastric Cancer Progression and Poor Survival of Patients , 2009, Clinical Cancer Research.
[27] M. Dwek,et al. Breast cancer progression is associated with a reduction in the diversity of sialylated and neutral oligosaccharides. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[28] J. Wakefield,et al. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. , 2005, Cancer research.
[29] Yehia Mechref,et al. Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. , 2010, Analytical chemistry.
[30] W. Alley,et al. Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. , 2010, Journal of proteome research.
[31] E. Gottlin,et al. Haptoglobin and posttranslational glycan‐modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer , 2007, Cancer.
[32] Philippe Delannoy,et al. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. , 2008, The Biochemical journal.
[33] Kiyoshi Ikeda,et al. Up-regulation of the expression of leucine-rich α2-glycoprotein in hepatocytes by the mediators of acute-phase response , 2009, Biochemical and Biophysical Research Communications.
[34] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[35] P. Malfertheiner,et al. Overexpression of cathepsin B in gastric cancer identified by proteome analysis , 2005, Proteomics.
[36] Jun Yu,et al. Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. , 2004, Journal of proteome research.
[37] P. Rudd,et al. Glycosylation of liver acute‐phase proteins in pancreatic cancer and chronic pancreatitis , 2010, Proteomics. Clinical applications.
[38] T. Ørntoft,et al. Clusterin Expression in Normal Mucosa and Colorectal Cancer*S , 2007, Molecular & Cellular Proteomics.
[39] S. Tatebe,et al. Serum interleukin-6 and -10 levels in patients with gastric cancer , 2009, Gastric Cancer.
[40] M. Goodarzi,et al. Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: glycan composition varies with disease , 1998, Glycoconjugate Journal.
[41] K. Kumamoto,et al. Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[42] Z. Ye,et al. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. , 2010, Human pathology.
[43] L. French,et al. Clusterin: modulation of complement function , 1994, Clinical and experimental immunology.
[44] Kathryn S Lilley,et al. Investigating sample pooling strategies for DIGE experiments to address biological variability , 2009, Proteomics.
[45] Kit S Lam,et al. Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. , 2006, Journal of proteome research.
[46] Michael S. Bereman,et al. The effects of abundant plasma protein depletion on global glycan profiling using NanoLC FT-ICR mass spectrometry , 2010, Analytical and bioanalytical chemistry.
[47] M. Gleave,et al. Clusterin Facilitates COMMD 1 and I-κ B Degradation to Enhance NF-κ B Activity in Prostate Cancer Cells , 2010 .
[48] S. Hanash,et al. Mining the plasma proteome for cancer biomarkers , 2008, Nature.
[49] A. Kobata,et al. Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours , 2005, Immunology and cell biology.
[50] Louise Royle,et al. Proposal for a standard system for drawing structural diagrams of N‐ and O‐linked carbohydrates and related compounds , 2009, Proteomics.
[51] R. Matthiesen,et al. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. , 2010, The international journal of biochemistry & cell biology.
[52] Terence C W Poon,et al. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. , 2006, Journal of proteome research.
[53] M. Tajiri,et al. Site‐specific analysis of N‐glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers , 2008, International journal of cancer.
[54] Qiaojia Huang,et al. Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology , 2008, Journal of Cancer Research and Clinical Oncology.
[55] Pauline M. Rudd,et al. Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis , 2009, Disease markers.
[56] B. Garner,et al. HPLC analysis of discrete haptoglobin isoform N-linked oligosaccharides following 2D-PAGE isolation. , 2006, Biochemical and biophysical research communications.
[57] M. Setou,et al. Imaging mass spectrometry of gastric carcinoma in formalin‐fixed paraffin‐embedded tissue microarray , 2010, Cancer science.
[58] T. Akahoshi,et al. Analysis of the Oligosaccharide Chain of Human Serum Immunoglobulin G in Patients with Localized or Metastatic Cancer , 2004, Oncology.
[59] Pauline M Rudd,et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. , 2007, Glycobiology.
[60] R. Dwek,et al. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. , 2006, Arthritis and rheumatism.
[61] M. Sobrinho-Simões,et al. Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. , 1998, Gastroenterology.
[62] H. Kato,et al. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer , 2007, Journal of Chromatography B.
[63] Y. Qu,et al. Comparative proteomics analysis of human gastric cancer. , 2008, World journal of gastroenterology.
[64] M. Nakano,et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: Detailed analyses of oligosaccharide structures , 2008, Proteomics.
[65] Tanasit Techanukul,et al. Comparison of three commercially available DIGE analysis software packages: minimal user intervention in gel-based proteomics. , 2009, Journal of proteome research.
[66] Pauline M Rudd,et al. The impact of glycosylation on the biological function and structure of human immunoglobulins. , 2007, Annual review of immunology.
[67] Tasneem H. Patwa,et al. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. , 2008, Journal of proteome research.
[68] J. Willis,et al. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer , 2006, Cell Death and Differentiation.
[69] S. Olofsson,et al. Activation of host antiviral RNA-sensing factors necessary for herpes simplex virus type 1-activated transcription of host cell fucosyltransferase genes FUT3, FUT5, and FUT6 and subsequent expression of sLe(x) in virus-infected cells. , 2009, Glycobiology.
[70] N. Yoo,et al. Expression of CARD6, an NF‐κB activator, in gastric, colorectal and oesophageal cancers , 2010, Pathology.
[71] D. Morton,et al. Glycoimmunomics of human cancer: current concepts and future perspectives. , 2007, Future oncology.
[72] R. Jemmerson,et al. Cytochrome c-induced lymphocyte death from the outside in: inhibition by serum leucine-rich alpha-2-glycoprotein-1 , 2010, Apoptosis.